© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
November 06, 2009
September 07, 2009
A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.
June 07, 2008
March 01, 2008
For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.
November 01, 1998